Literature DB >> 7129011

Comparative immunological studies in rats following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors.

K Hayakawa, T Yamashita, K Suzuki, K Tomita, M Hosokawa, T Kodama, H Kobayashi.   

Abstract

Post-operative antitumor immunity was studied by comparing the results following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors in WKA/Hok rats. Immunity was tested by challenge with the autochthonous tumors on the 4th and 21st days post-operatively. Antitumor resistance which developed following cryosurgery was found in 7 out of 14 rats (50%) challenged after 4 days and in 2 out of 13 rats (15%) challenged after 21 days. Following surgical excision, however, resistance was found in 13 out of 18 rats (72%) challenged after 4 days and in 10 out of 17 rats (58%) challenged after 21 days. Therefore, the development of antitumor immunity by surgical excision was more effective than by cryosurgery (P less than 0.02). In addition, the enhancement of autochthonous tumor growth as compared with that of the control rats was clearly demonstrated after cryosurgery in 4 out of 14 rats (29%) challenged 4 days afterwards and in 3 out of 13 rats (23%) challenged 21 days afterwards. After surgical excision, however, this was seen in only 3 out of 18 rats (17%) challenged 4 days afterwards, and in 0 out of 17 rats (0%) challenged 21 days afterwards. These results suggest not only that the development of antitumor immunity is delayed but also that the tumor growth is more likely to be enhanced by cryosurgery than by surgical excision.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129011

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  5 in total

1.  Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.

Authors:  Rebecca Waitz; Stephen B Solomon; Elena N Petre; Anne E Trumble; Marcella Fassò; Larry Norton; James P Allison
Journal:  Cancer Res       Date:  2011-11-22       Impact factor: 12.701

Review 2.  More than just tumor destruction: immunomodulation by thermal ablation of cancer.

Authors:  Sebastian P Haen; Philippe L Pereira; Helmut R Salih; Hans-Georg Rammensee; Cécile Gouttefangeas
Journal:  Clin Dev Immunol       Date:  2011-12-29

Review 3.  Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response?

Authors:  Amol Mehta; Rahmi Oklu; Rahul A Sheth
Journal:  Gastroenterol Res Pract       Date:  2016-03-08       Impact factor: 2.260

4.  Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.

Authors:  Noritaka Yonezawa; Hideki Murakami; Satoru Demura; Satoshi Kato; Shinji Miwa; Katsuhito Yoshioka; Kazuya Shinmura; Noriaki Yokogawa; Takaki Shimizu; Norihiro Oku; Ryo Kitagawa; Makoto Handa; Ryohei Annen; Yuki Kurokawa; Kazumi Fushimi; Eishiro Mizukoshi; Hiroyuki Tsuchiya
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

5.  Effects of a combination of cyclophosphamide and human recombinant interleukin 2 on pulmonary metastasis after the surgical removal of a 3-methylcholanthrene-induced primary tumor in autochthonous mice.

Authors:  M Hosokawa; T Yabiku; J Ikeda; Y Sawamura; F Okada; M Komatsumoto; T Tanabe; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1988-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.